Tools   Select Another Resource Report Type

http://www.nih.gov/

NIH is the nations medical research agency - making important medical discoveries that improve health and save lives. The National Institutes of Health (NIH), a part of the U.S. Department of Health and Human Services, is the primary Federal agency for conducting and supporting medical research. Helping to lead the way toward important medical discoveries that improve peoples health and save lives, NIH scientists investigate ways to prevent disease as well as the causes, treatments, and even cures for common and rare diseases. NIH research impacts: * child and teen health, * men's health, * minority health, * seniors' health, * women's health, and * wellness and lifestyle issues. Composed of 27 Institutes and Centers, the NIH provides leadership and financial support to researchers in every state and throughout the world.

Proper citation: National Institutes of Health (RRID:SCR_011417) Copy   

•   Source: SciCrunch Registry
  

https://dmptool.org

Free web application which guides users through the process of creating a data management plan (DMP) for a range of funders (NSF, NIH, etc.) and connect users with data management planning resources. The DMPTool allows users to edit, save, share, print, and download their data management plans. Institutions can customize the tool and configure Shibboleth login. Several universities and organizations are developing the DMPTool to help researchers meet these new requirements. In specific, the DMPTool will help researchers: * Create ready-to-use data management plans for specific funding agencies * Meet requirements for data management plans * Get step-by-step instructions and guidance for data management plan * Learn about resources and services available at your institution to fulfill the data management requirements of their grants

Proper citation: DMPTool (RRID:SCR_002623) Copy   

•   Source: SciCrunch Registry
  

http://grants.nih.gov/podcasts/All_About_Grants/index.htm

The Office of Extramural Research (OER) presents conversations with NIH staff members. Designed for investigators, fellows, students, research administrators, and others, we provide insights on grant topics from those who live and breathe the information. In mp3 and updated monthly. Transcripts are also available. So You Wanna... Keep Up with What''''s Hot? Prepare a Successful Grant Application? Suggest a Topic? Understand How Your Grant is Reviewed? Be an NIH Investigator?

Proper citation: All About Grants Podcast (RRID:SCR_005621) Copy   

•   Source: SciCrunch Registry
  

http://www.brimr.org/NIH_Awards/2010/NIH_Awards_2010.htm

Excel files available for download of ranking tables of NIH Funding to US Medical Schools in 2010, school and Principal Investigator (PI) rankings by Medical School Department, direct plus indirect costs (excluding both R & D contracts and American Recovery and Reinvestment Act (ARRA) Awards), etc. Categories under the Basic Science Department and Clinical Science Department are available as well as the rank of each School of Medicine from 2001-2010. The data in the 2010 Award files was obtained from the Research Portfolio Online Reporting Tool (RePORT) from the National Institutes of Health at http://report.nih.gov/award/trends/AggregateData.cfm. The Award Data correspond to the US Government fiscal year. Awards for 2010 correspond to those granted from 1 October 2009-30 September 2010. There is considerable variation on how universities credit awards and how the NIH deals with these variations.

Proper citation: Ranking Tables of NIH Funding to US Medical Schools in 2010 (RRID:SCR_013272) Copy   

•   Source: SciCrunch Registry
  

http://www.hhs.gov/grants/

http://www.hhs.gov/grants/

Proper citation: United States Department of Health and Human Services granting agency (RRID:SCR_011596) Copy   

•   Source: SciCrunch Registry
  

http://www.sfn.org/siteobjects/published/0000BDF20016F63800FD712C30FA42DD/B7DCEFADE2FDB93B95188E3FD01E2FF0/file/Neurofed%202009c.pdf

THIS RESOURCE IS NO LONGER IN SERVICE, documented on August 26, 2016. The NeuroFed resource is a listing of neuroscience research funding contacts in the Federal government. It is an informal compendium (PDF) of names and contact information for nearly 300 research grant and scientific review administrators in 21 organizational units of the federal government. An electronic (PDF) version of the most recent update of this list is available on the Society for Neuroscience website at: http://www.sfn.org/index.aspx?pagename=professionalDevelopment_training. The list is updated annually by NIH personnel.

Proper citation: Neurofed (RRID:SCR_002011) Copy   

•   Source: SciCrunch Registry
  

http://www.bioconductor.org/packages/release/bioc/html/GEOquery.html

Software that establishes a bridge between GEO and BioConductor.

Proper citation: GEOquery (RRID:SCR_000146) Copy   

•   Source: SciCrunch Registry
  

http://www.tarp.nih.gov/

Trans-NIH program encouraging and facilitating the study of the underlying mechanisms controlling blood vessel growth and development. Other aims include: to identify specific targets and to develop therapeutics against pathologic angiogenesis in order to reduce the morbidity due to abnormal blood vessel proliferation in a variety of disease states; to better understand the process of angiogenesis and vascularization to improve states of decreased vascularization; to encourage and facilitate the study of the processes of lymphangiogenesis; and to achieve these goals through a multidisciplinary approach, bringing together investigators with varied backgrounds and varied interests.

Proper citation: Trans-Institute Angiogenesis Research Program (RRID:SCR_000384) Copy   

•   Source: SciCrunch Registry
  

https://rarediseases.org/organizations/nihoffice-of-rare-disease-research/

Organization which develops and maintains a centralized database on rare disease clinical research supported by the NIH. It also stimulates rare disease research by supporting scientific workshops and symposia, responds to requests for information on highly technical matters and matters of public policy, provides information to the Office of the Director on matters relating to rare diseases and orphan products, and coordinates and serves as a liaison with Federal and non-Federal national and international organizations.

Proper citation: Office of Rare Diseases Research (RRID:SCR_004121) Copy   

•   Source: SciCrunch Registry
  

http://gds.nih.gov/

NIH established expectations for sharing data obtained through NIH-funded genome-wide association studies (GWAS) with the implementation of the GWAS Policy. Information and resources related to the GWAS Policy can be found on this website.

Proper citation: Genomic Datasharing (RRID:SCR_005233) Copy   

•   Source: SciCrunch Registry
  

http://science.education.nih.gov/home2.nsf/feature/index.htm

The NIH Office of Science Education (OSE) coordinates science education activities at the NIH and develops and sponsors science education projects in house. These programs serve elementary, secondary, and college students and teachers and the public. Activities * Develop curriculum supplements and other educational materials related to medicine and research through collaborations with scientific experts at NIH * Maintain a website as a central source of information about NIH science education resources * Establish national model programs in public science education, such as the NIH Mini-Med School and Science in the Cinema * Promote science education reform as outlined in the National Science Education Standards and related guidelines The OSE was established in 1991 within the Office of Science Policy of the Office of the Director of the National Institutes of Health. The NIH is the world''s foremost biomedical research center and the U.S. federal government''s focal point for such research. It is one of the components of the Department of Health and Human Services (HHS). The Office of Science Education (OSE) plans, develops, and coordinates a comprehensive science education program to strengthen and enhance efforts of the NIH to attract young people to biomedical and behavioral science careers and to improve science literacy in both adults and children. The function of the Office is as follows: (1) develops, supports, and directs new program initiatives at all levels with special emphasis on targeting students in grades kindergarten to 16, their educators and parents, and the general public; (2) advises NIH leadership on science education issues; (3) examines and evaluates research and emerging trends in science education and literacy for policy making; (4) works closely with the NIH extramural, intramural, women''s health, laboratory animal research, and minority program offices on science education special issues and programs to ensure coordination of NIH efforts; (5) works with NIH institutes, centers, and divisions to enhance communication of science education activities; and (6) works cooperatively with other public- and private-sector organizations to develop and coordinate activities.

Proper citation: NIH Office of Science Education (RRID:SCR_005603) Copy   

•   Source: SciCrunch Registry
  

http://grants.nih.gov/grants/oer.htm

OER serves as a vital interface between the NIH and the biomedical research community by guiding investigators through the process of attaining grants funding and helping them understand and navigate through federal policies and procedures. OER supports extramural research by providing policy and guidance to the 24 NIH Institutes and Centers that award grants. Extramural grants account for approximately 84 percent of NIH''s 29 billion budget. These are awarded to investigators throughout the U.S. and abroad. Approximately 10 percent of the NIH budget supports NIH intramural investigators, NIH staff who conduct research.

Proper citation: Office of Extramural Research NIH (RRID:SCR_006547) Copy   

•   Source: SciCrunch Registry
  

http://www.prize4life.org/

Prize4Life is a 501(c)(3) nonprofit organization dedicated to accelerating the discovery of treatments and cures for ALS (amyotrophic lateral sclerosis, also known as Lou Gehrig''s disease). Our mission is to accelerate the discovery of a treatment and a cure for ALS by using powerful incentives to attract new people and new ideas and to leverage existing efforts and expertise in the ALS field. Our Values: * Patients first. Avichai Kremer, one of the Harvard Business School students who founded Prize4Life, was diagnosed with ALS in 2004. We therefore know the disease firsthand and have a sense of urgency to find a treatment. We value patients and their viewpoints. Patients, please tell us what you think. * Global awareness. We plan to push ALS to the forefront of fatal disease issues. We need your help in order to do this. Get involved. * New people and new ideas. We believe important breakthroughs in ALS may reside in the minds and laboratories of people who are not currently researching the disease. Our platform is a bridge for reaching these people. Enter the competition. * Results. Research is traditionally funded upfront, before an idea is even tested. Our prize model ensures that only clear research results, vetted by a team of scientific advisors, are rewarded. grants; funding resource;.

Proper citation: Prize4Life (RRID:SCR_006558) Copy   

•   Source: SciCrunch Registry
  

http://painconsortium.nih.gov/

The NIH Pain Consortium was established to enhance pain research and promote collaboration among researchers across the many NIH Institutes and Centers that have programs and activities addressing pain. To this end, the following goals have been identified for the Pain Consortium: * To develop a comprehensive and forward-thinking pain research agenda for the NIH - one that builds on what we have learned from our past efforts. * To identify key opportunities in pain research, particularly those that provide for multidisciplinary and trans-NIH participation. * To increase visibility for pain research - both within the NIH intramural and extramural communities, as well as outside the NIH. The latter audiences include our various pain advocacy and patient groups who have expressed their interests through scientific and legislative channels. * To pursue the pain research agenda through Public-Private partnerships, wherever applicable. This underscores a key dynamic that has been reinforced and encouraged through the Roadmap process.

Proper citation: NIH Pain Consortium (RRID:SCR_006767) Copy   

•   Source: SciCrunch Registry
  

http://www.cit.nih.gov/

The Center for Information Technology''s (CIT) mission is to provide, coordinate, and manage information technology and to advance computational science. CIT incorporates the power of modern computers into the biomedical programs and administrative procedures of the NIH by focusing on three primary activities: conducting computational biosciences research, developing computer systems, and providing computer facilities. CIT supports NIH''s research and management programs with efficient, cost-effective administrative and high-powered scientific computing, software development, networking, and telecommunications services. CIT also provides bioinformatics support through its scientists, engineers, and mathematicians. Among its activities, the CIT: * engages in collaborative research and provides collaborative support to NIH investigators in the area of computational bioscience * provides efficient, cost-effective information systems and networking services * provides state-of-the-art scientific and administrative computing facilities * identifies new computing technologies with innovative applications to biomedical research * creates, purchases, and distributes software applications * provides NIH staff with computing information, expertise, and training * provides data-processing and high-performance computing facilities, integrated telecommunications data networks, and services to the U.S. Department of Health and Human Service (HHS) and other Federal agencies * serves as a data center to HHS and other Federal agencies * develops, administers, and manages NIH systems and provides consulting services to NIH Institutes and Centers in support of administrative and business applications

Proper citation: Center for Information Technology (RRID:SCR_011143) Copy   

•   Source: SciCrunch Registry
  

http://www.nih.gov/about/almanac/organization/NCRR.htm

A former institute of the NIH that, for 50 years, provided laboratory scientists and clinical researchers with the tools and training they needed to understand, detect, treat, and prevent a wide range of diseases. They supported all aspects of clinical and translational research, connecting researchers, patients, and communities across the nation. This support enabled discoveries made at a molecular and cellular level to move to animal-based studies, and then to patient-oriented clinical research, ultimately leading to improved patient care. Through programs such as the Clinical and Translational Science Awards, they brought together innovative research teams and equiped them with essential tools and critical resources needed to tackle the nations complex health problems. NCRR, through all of its programs, sparked innovation and leveraged shared resources to: * Establish clinical research infrastructure, including specialized research staff, informatics support, and laboratories that enable studies of the full range of human disorders. * Fund career development programs that attract talented medical students, physicians, and dentists to the challenge of clinical research careers. * Enhance development programs for underserved states and institutions, focusing on health disparities that negatively impact racial and ethnic minority populations. * Stimulate basic research to develop versatile new technologies and methods that help researchers to study virtually every human disease. * Provide access to state-of-the art technologies and instruments that enable both basic biomedical research and clinical investigations of a multitude of health issues, from cancer to infectious diseases. * Develop and provide access to critical animal models, which offer essential clues to a broad range of human disorders such as Parkinson''s disease, multiple sclerosis, and AIDS. * Train veterinarians in translational research in order to respond to deadly human diseases, such SARS, influenza, and hepatitis. * Provide funding to expand, remodel, and renovate or alter existing research facilities or construct new research facilities. * Improve the public understanding of medical research and provide adults and children with information about healthy living and science career opportunities.

Proper citation: National Center for Research Resources (RRID:SCR_011408) Copy   

•   Source: SciCrunch Registry
  

http://nccam.nih.gov/

The National Center for Complementary and Alternative Medicine (NCCAM) is the Federal Government''s lead agency for scientific research on the diverse medical and health care systems, practices, and products that are not generally considered part of conventional medicine. The mission of NCCAM is to define, through rigorous scientific investigation, the usefulness and safety of complementary and alternative medicine interventions and their roles in improving health and health care. NCCAM sponsors and conducts research using scientific methods and advanced technologies to study CAM. CAM is defined simply as a group of diverse medical and health care interventions, practices, products, or disciplines that are not generally considered part of conventional medicine. NCCAM has four primary areas of focus: # Advancing scientific research: We fund research projects at scientific institutions across the United States and around the world. # Training CAM researchers: We support training for new researchers as well as encourage experienced researchers to study CAM. # Sharing news and information: We provide timely and accurate information about CAM research in many ways, such as through our Web site, Twitter, Facebook, and other social media tools, our information clearinghouse, fact sheets, Lecture Series, and continuing medical education programs. # Supporting integration of proven CAM therapies: Our research helps the public and health professionals understand which CAM therapies have been proven to be safe and effective. We are 1 of the 27 institutes and centers that make up the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services.

Proper citation: National Center for Complementary and Alternative Medicine (RRID:SCR_011405) Copy   

•   Source: SciCrunch Registry
  

http://neuroscienceblueprint.nih.gov/

Collaborative framework that includes the NIH Office of the Director and the 14 NIH Institutes and Centers that support research on the nervous system. By pooling resources and expertise, the Blueprint identifies cross-cutting areas of research, and confronts challenges too large for any single Institute or Center. The Blueprint makes collaboration a day-to-day part of how the NIH does business in neuroscience, complementing the basic missions of Blueprint partners. During each fiscal year, the partners contribute a small percentage of their funds to a common pool. Since the Blueprint's inception in 2004, this pool has comprised less than 1 percent of the total neuroscience research budget of the partners. In 2009, the Blueprint Grand Challenges were launched to catalyze research with the potential to transform our basic understanding of the brain and our approaches to treating brain disorders. * The Human Connectome Project is an effort to map the connections within the healthy brain. It is expected to help answer questions about how genes influence brain connectivity, and how this in turn relates to mood, personality and behavior. The investigators will collect brain imaging data, plus genetic and behavioral data from 1,200 adults. They are working to optimize brain imaging techniques to see the brain's wiring in unprecedented detail. * The Grand Challenge on Pain supports research to understand the changes in the nervous system that cause acute, temporary pain to become chronic. The initiative is supporting multi-investigator projects to partner researchers in the pain field with researchers in the neuroplasticity field. * The Blueprint Neurotherapeutics Network is helping small labs develop new drugs for nervous system disorders. The Network provides research funding, plus access to millions of dollars worth of services and expertise to assist in every step of the drug development process, from laboratory studies to preparation for clinical trials. Project teams across the U.S. have received funding to pursue drugs for conditions from vision loss to neurodegenerative disease to depression. Since its inception in 2004, the Blueprint has supported the development of new resources, tools and opportunities for neuroscientists. For example, the Blueprint supports several training programs to help students pursue interdisciplinary areas of neuroscience, and to bring students from underrepresented groups into the neurosciences. The Blueprint also funds efforts to develop new approaches to teaching neuroscience through K-12 instruction, museum exhibits and web-based platforms. From fiscal years 2007 to 2009, the Blueprint focused on three major themes of neuroscience - neurodegeneration, neurodevelopment, and neuroplasticity. These efforts enabled unique funding opportunities and training programs, and helped establish new resources including the Blueprint Non-Human Primate Brain Atlas.

Proper citation: NIH Blueprint for Neuroscience Research (RRID:SCR_003670) Copy   

•   Source: SciCrunch Registry
  

http://www.asn-online.org/khi/

Consortium that brings together the kidney community (patient advocacy groups, industry, government agencies, and professional organizations) to overcome existing challenges, including regulatory and nonregulatory barriers, and optimize the development and safety of products that impact kidney health including drugs, devices, biologics, and food products. The goals of the consortium are to: * Facilitate dialogue and research that informs regulatory processes with regard to the kidney health of patients being treated for kidney-related as well as other diseases. * Assess current medical therapies and diagnostics to identify areas in need of greater innovation and/or better defined regulatory pathways. * Develop innovative and efficient trial designs appropriate to answer the most important questions related to kidney health. * Establish expert consensus around common terminology and key definitions related to kidney health. * Develop approaches to the systematic collection of retrospective or prospective data, such as registries and/or global databases, and establishment of data standards. * Coordinate think tanks, public forums, educational exchanges, and other events to promote discussion and updates on topics in kidney health pertaining to drug, device, biologics, and food product development and evaluation. * Create transparent infrastructure and processes that facilitate collaboration and communication among the greater nephrology community and the FDA, including: * Seek input from all stakeholders (including nephrologists and other health professionals, patient groups, industry, the National Institutes of Health, the Centers for Medicare and Medicaid Services, the Health Resources and Services Administration, and other federal agencies). * Leverage previously conducted and ongoing clinical studies, research infrastructure, and databases. * Create an open and efficient mechanism for encouraging and objectively evaluating potential projects submitted to KHI. * Involve consortium members in the selection and execution of projects. * Establish systems to optimize post-market surveillance of products that affect kidney health, either intentionally or via adverse drug reactions. * Author journal articles and white papers regarding key issues, describing opportunities and challenges and proposing solutions, as well as promoting execution of these solutions.

Proper citation: Kidney Health Initiative (RRID:SCR_003869) Copy   

•   Source: SciCrunch Registry
  

http://www.nhlbi.nih.gov/

NHLBI provides leadership for a national program in diseases of the heart, blood vessels, lung, and blood; blood resources; and sleep disorders. Since October 1997, the NHLBI has also had administrative responsibility for the NIH Woman''s Health Initiative. The Institute plans, conducts, fosters, and supports an integrated and coordinated program of basic research, clinical investigations and trials, observational studies, and demonstration and education projects. The National Heart, Lung, and Blood Institute (NHLBI) provides global leadership for a research, training, and education program to promote the prevention and treatment of heart, lung, and blood diseases and enhance the health of all individuals so that they can live longer and more fulfilling lives. The NHLBI stimulates basic discoveries about the causes of disease, enables the translation of basic discoveries into clinical practice, fosters training and mentoring of emerging scientists and physicians, and communicates research advances to the public. It creates and supports a robust, collaborative research infrastructure in partnership with private and public organizations, including academic institutions, industry, and other government agencies. The Institute collaborates with patients, families, health care professionals, scientists, professional societies, patient advocacy groups, community organizations, and the media to promote the application of research results and leverage resources to address public health needs. The NHLBI also collaborates with international organizations to help reduce the burden of heart, lung, and blood diseases worldwide.

Proper citation: National Heart Lung and Blood Institute (RRID:SCR_011413) Copy   

•   Source: SciCrunch Registry